SA Rosenberg, MT LOTZE, JJ MULE - Annals of internal medicine, 1988 - Am Coll Physicians Experimental studies in animals have shown that therapy with high-dose
interleukin-2 either alone or in combination with lymphokine-activated killer
cells can reduce established pulmonary and hepatic metastases. Based on ... Cited by 151 - Related articles - All 3 versions
G Sarna, J Collins, R Figlin, P Robertson, B … - Journal of Immunotherapy, 1990 - journals.lww.com Summary: Interleukin-2 (recombinant methionyl human interleukin-2 alanine 125;
IL-2) was administered intralymphatically to 12 patients with advanced cancer in
a phase I trial. Doses were administered once a week for 6 weeks in a ... Cited by 18 - Related articles - All 2 versions
L Gandolfi, L Solmi, GC Pizza, F Bertoni, R … - Hepato-gastroenterology, 1989 - cat.inist.fr Intratumoral echo-guided injection of interleukin-2 and lymphokine-activated
killer cells in hepatocellular carcinoma. L GANDOLFI ... Cited by 21 - Related articles - All 3 versions
G Pizza, D Viza, C De Vinci, PJM Vich, L … - Lymphokine research, 1988 - ncbi.nlm.nih.gov Seven patients suffering from advanced metastatic tumours, unresponsive to
standard therapies, were treated with 3 to 5 intra-lymphatic injections of
interleukin-2 (IL-2) and IL-2-activated-peripheral blood lymphocytes (PBL). ... Cited by 16 - Related articles - All 2 versions
JL Gabrilove, A Jakubowski - Journal of the National Cancer Institute. Monographs, 1990 - ncbi.nlm.nih.gov A number of recently identified cytokines have been implicated in the
development of blood cells and their functional activation. These include
granulocyte colony-stimulating factor (G-CSF), granulocyte/macrophage ... Cited by 23 - Related articles
MT Lotze, AE Chang, CA Seipp, C Simpson, … - Jama, 1986 - Am Med Assoc Experience with the administration of high doses of interleukin 2 (IL-2) alone
is described herein. Ten patients with a variety of malignant disorders
unresponsive to conventional treatments were treated with at least 30,000 ... Cited by 305 - Related articles - All 3 versions
EC Borden, PM Sondel, T Biosciences, H … - CA A Cancer Journal for Clinicians - interscience.wiley.com Human proteins with identified effects on host responses to malignant cells have
been established as effective therapeutic techniques in cancer. Lymphokines,
products of activated cells of the immune system, have pleiotropic ... Cited by 80 - Related articles - All 2 versions
A Kelso - Current opinion in immunology, 1989 - ncbi.nlm.nih.gov 1: Curr Opin Immunol. 1989 Dec;2(2):215-25. Cytokines: structure, function
and synthesis. Kelso A. Walter and Eliza Hall Institute ... Cited by 63 - Related articles
J Bubenik, NN Voitenok, J Kieler, VS … - Immunology letters, 1988 - ncbi.nlm.nih.gov We have prepared a retroviral expression construct, pPS-IL-2, in which human
IL-2 cDNA has been inserted into the polylinker region, and have used the
retroviral vector to introduce the functional IL-2 gene into a fibroblast ... Cited by 55 - Related articles
RI FISHER, CA COLTMAN Jr, JH DOROSHOW … - Annals of internal medicine, 1988 - Am Coll Physicians RICHARD I. FISHER, MD; CHARLES A. COLTMAN, Jr., MD; JAMES H. DOROSHOW, MD;
ANTHONY A. RAYNER, MD; MICHAEL J. HAWKINS, MD; JAMES W. MIER, MD; PETER WIERNIK,
MD; JOHN D. MCMANNIS, Ph.D.; GEOFFREY R. WEISS, MD; KIM A. MARGOLIN, MD; ... Cited by 265 - Related articles - All 4 versions
